pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

2,316 catalysts · 3,045 8k filing · 2,096 grant · 1,160 approval · 1,000 device adverse event · 874 device 510k · 623 device pma

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-10: 0 catalysts2026-08-11: 16 catalysts2026-08-12: 19 catalysts2026-08-13: 19 catalysts2026-08-14: 4 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 1 catalyst2026-08-18: 2 catalysts2026-08-19: 2 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 1 catalyst2026-08-27: 1 catalyst2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 21 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 8 catalysts2026-11-03: 17 catalysts2026-11-04: 22 catalysts2026-11-05: 36 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts
view
agendamonth
sort
soonestlatesttypesponsoralpha
type: grant×type: recall×from 2026-01-06×clear all
type
  • 8k filing3,045
  • grant2,096
  • approval1,160
  • device adverse event1,000
  • device 510k874
  • device pma623
earnings
579
  • device recall403
  • recall220
  • phase 2 completion172
  • therapy area

    no tagged catalysts yet

    Week of Jan 5, 2026

    13
    ›Jan 6, 2026grant217d agoUNIVERSITY OF WASHINGTON — Real-time imaging of opioid neuromodulation with novel genetically encoded fl...University of Washington

    DA grant. $49,538. PI: Lily Torp

    full page →nih reporter ↗
    ›Jan 6, 2026grant217d agoOREGON HEALTH & SCIENCE UNIVERSITY — Metabolic coupling of oligodendroglia and endothelial cells through cell-spec...

    NS grant. $74,632. PI: THADDEUS KUNKEL

    full page →nih reporter ↗
    ›Jan 6, 2026grant217d agoRUTGERS BIOMEDICAL AND HEALTH SCIENCES — Polarity dysregulation in Alzheimer’s disease

    NS grant. $50,000. PI: Huaye Zhang

    full page →nih reporter ↗
    ›Jan 7, 2026recall216d agoZydus Pharmaceuticals (USA) Inc recall (Cls III)LB PHARMACEUTICALS INC

    traZODONE Hydrochloride Tablets, USP, 100mg, 1,000 Tablets, Rx only, Manufactured by: Zydus Lifesciences Ltd., India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 68382-806-10 — Reason: Failed Tablet/Capsule Specifications: Product complaint received that some tablets had a dent on the plain side of the tablet surface. — Status: Ongoing

    full page →fda recalls ↗
    ›Jan 7, 2026recall216d agoGlenmark Pharmaceuticals Inc., USA recall (Cls II)LB PHARMACEUTICALS INC

    Ondansetron Orally Disintegrating Tablets, USP, 4mg, 30 Tablets (3 blistercards each containing 10 tablets), Rx only, Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430, Product of India, NDC 68462-157-13 — Reason: Defective container: Preferred Pharmaceuticals received a letter from the manufacturer Glenmark, that the blister packs are not fully sealed and tablets falling out. Preferred Pharmaceuticals purchased the finished product and repackaged the product for sale. — Status: Ongoing

    full page →fda recalls ↗
    ›Jan 7, 2026recall216d agoNovo Nordisk Inc. recall (Cls II)NOVO NORDISK A S

    Wegovy (semaglutide) Injection, 1 mg/0.5 mL, 4 Single-Dose Prefilled Pens, Manufactured by: Novo Nordisk A/S, DK-2880 Bagsvaerd, Denmark, Product of Denmark, Novo Nordisk A/S, Novo Nordisk Inc., Plainsboro, NJ 08536, NDC 0169-4501-14 — Reason: Presence of Particulate Matter: Hair was found in a prefilled syringe — Status: Ongoing

    full page →fda recalls ↗
    ›Jan 7, 2026recall216d agoNovo Nordisk Inc. recall (Cls II)NOVO NORDISK A S

    Wegovy (semaglutide) Injection, 0.5 mg/0.5 mL, 4 Single-Dose Prefilled Pens, Manufactured by: Novo Nordisk A/S, DK-2880 Bagsvaerd, Denmark, Product of Denmark, Novo Nordisk A/S, Novo Nordisk Inc., Plainsboro, NJ 08536, NDC 0169-4505-14 — Reason: Presence of Particulate Matter: Hair was found in a prefilled syringe — Status: Ongoing

    full page →fda recalls ↗
    ›Jan 7, 2026recall216d agoCareFusion 213, LLC recall (Cls II)Coorg Instituite of Dental Sciences

    BD ChloraPrep" Triple Swabsticks (Chlorhexidine gluconate (CHG), 2% w/v and Isopropyl alcohol (IPA), 70% v/v), 5.25 mL Applicator, CareFusion 213, LLC, El Paso, TX 79912, NDC 54365-401-29 — Reason: Lack of Assurance of Sterlity — Status: Ongoing

    full page →fda recalls ↗
    ›Jan 7, 2026grant216d agoWEILL MEDICAL COLL OF CORNELL UNIV — RNA's Role in Double-Strand Break Repair

    CA grant. $49,538. PI: Hina Shah

    full page →nih reporter ↗
    ›Jan 7, 2026grant216d agoWEST VIRGINIA UNIVERSITY — Proteasome function in neurodegenerative disease

    NS grant. $567,047. PI: David Matthew Smith

    full page →nih reporter ↗
    ›Jan 8, 2026grant215d agoALASKA NATIVE TRIBAL HEALTH CONSORTIUM — Traditional foods and health: A Community-Based Approach to Improving Food Se...

    GM grant. $140,056. PI: Ruby Fried

    full page →nih reporter ↗
    ›Jan 9, 2026grant214d agoSANFORD RESEARCH NORTH — Momentary predictors and moderators of eating disorder behaviors and self-harm

    GM grant. $312,417. PI: Dorian R Dodd

    full page →nih reporter ↗
    ›Jan 9, 2026grant214d agoUNIVERSITY OF TOLEDO HEALTH SCI CAMPUS — Influence of arginine on Klebsiella pneumoniae mucoidy and pathogenesis

    AI grant. $39,066. PI: Brooke Ring

    full page →nih reporter ↗

    Week of Jan 12, 2026

    37
    ›Jan 12, 2026grant211d agoUNIVERSITY OF CALIFORNIA, SAN FRANCISCO — Exploring leaderless mRNA translation, a potential Achilles heel of mycobacteriaUniversity of California San Francisco

    AI grant. $75,052. PI: Sarah C Feid

    full page →nih reporter ↗
    ›Jan 12, 2026grant
    ← prev
    page 1 of 47
    next →
    211d ago
    ARKANSAS CHILDREN'S HOSPITAL RES INST — Growing Healthy Children and Families in Rural Arkansas

    GM grant. $132,469. PI: Martha Rojo

    full page →nih reporter ↗
    ›Jan 12, 2026grant211d agoUNIVERSITY OF COLORADO — Adolescent Friendship Networks: Effects on Immigrant Youth’s Psychosocial Health

    HD grant. $248,995. PI: Thoa Khuu

    full page →nih reporter ↗
    ›Jan 12, 2026grant211d agoNEW YORK UNIVERSITY SCHOOL OF MEDICINE — Mechanistic Insights Underlying LZTR1-Related SchwannomatosisNew York University

    NS grant. $579,610. PI: Pau Castel

    full page →nih reporter ↗
    ›Jan 12, 2026grant211d agoUNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR — STRONG HEART STUDY (SHS) - UNIVERSITY OF OKLAHOMA, FIELD CENTER (FC), TASK AR...

    HL grant. $469,049. PI: nagendra monangi

    full page →nih reporter ↗
    ›Jan 12, 2026grant211d agoMISSOURI BREAKS RESEARCH, INC. — STRONG HEART STUDY (SHS) - MISSOURI BREAKS INDUSTRIES RESEARCH, INC., FIELD C...

    HL grant. $154,846. PI: HELAINE E. RESNICK

    full page →nih reporter ↗
    ›Jan 12, 2026grant211d agoMEDSTAR HEALTH RESEARCH INSTITUTE — STRONG HEART STUDY (SHS) - MEDSTAR HEALTH RESEARCH INSTITUTE, INC., FIELD CEN...

    HL grant. $129,024. PI: DEDRA S BUCHWALD

    full page →nih reporter ↗
    ›Jan 12, 2026grant211d agoCOLORADO STATE UNIVERSITY — Transmission dynamics and fitness of reemerging St. Louis encephalitis virus ...

    AI grant. $87,244. PI: Jenny Ann Buczek

    full page →nih reporter ↗
    ›Jan 13, 2026grant210d agoBECKMAN RESEARCH INSTITUTE/CITY OF HOPE — The role of ALKBH5-mediated RNA demethylation in the maintenance of genomic s...City of Hope

    DK grant. $450,479. PI: Zhijian Qian

    full page →nih reporter ↗
    ›Jan 14, 2026recall209d agoMedinatura New Mexico, inc. recall (Cls I)

    ClearLife Allergy Nasal Spray, Extra Strength, 0.68 fl. oz. (20 mL) bottles, Distributed by: MediNatura, 10421 Research Rd., SE, Albuquerque, NM 87123, NDC 62795-4006-9, UPC 787647101887 — Reason: Microbial Contamination of Non-Sterile Products: The products have been found to contain yeast/mold and microbial contamination identified as Achromobacter. — Status: Ongoing

    full page →fda recalls ↗
    ›Jan 14, 2026recall209d agoSpecGx, LLC recall (Cls II)SpecGx LLC

    Oxycodone and Acetaminophen CII Tablets USP, 10mg/325 mg, 100 tablets, Rx only, SpecGx LLC, Webster Groves, MO 63119, NDC 0406-0523-01. — Reason: Failed Tablet/Capsule Specification: There is a potential for the imprint to be missing on tablets. — Status: Ongoing

    full page →fda recalls ↗
    ›Jan 14, 2026recall209d agoImprimis NJOF, LLC recall (Cls II)Fosun Pharma USA Inc

    Tri-Moxi+¿ (Triamcinolone 9mg/0.6mL, Moxifloxacin 0.6 mg/ 0.6 mL) Single-Use Intraocular Injection, Imprimis NJOF, LLC., 1705 Route 46 West, Unit 6B, Ledgewood, NJ 07852. NDC 71384-746-06. — Reason: Presence of particulate matter - Glass like particles. — Status: Ongoing

    full page →fda recalls ↗
    ›Jan 14, 2026recall209d agoMedinatura New Mexico, inc. recall (Cls I)

    ReBoost Nasal Spray, 0.68 fl. oz. (20 mL) bottles, Distributed by: MediNatura, 10421 Research Rd., SE, Albuquerque, NM 87123, NDC 62795-4005-9, UPC 787647101863 — Reason: Microbial Contamination of Non-Sterile Products: The products have been found to contain yeast/mold and microbial contamination identified as Achromobacter. — Status: Ongoing

    full page →fda recalls ↗
    ›Jan 14, 2026recall209d agoSignature Formulations, LLC recall (Cls II)

    ORL Kids Mouthwash, Bubblegum Flavor, 16.9 oz. (500ml) per bottle, ORL Labs, LLC, Scottsdale, Arizona USA — Reason: cGMP Deviations — Status: Ongoing

    full page →fda recalls ↗
    ›Jan 14, 2026recall209d agoSpecGx, LLC recall (Cls II)SpecGx LLC

    Oxycodone and Acetaminophen CII Tablets USP, 7.5 mg/325 mg, 100 tablets, Rx only, SpecGx LLC, Webster Groves, MO 63119, NDC 0406-0522-01. Case label: SpecGx LLC, NDC 0406052201, Exp. 2027/03, Lot: 0522J23493 — Reason: Failed Tablet/Capsule Specification: There is a potential for the imprint to be missing on tablets. — Status: Ongoing

    full page →fda recalls ↗
    ›Jan 14, 2026recall209d agoSignature Formulations, LLC recall (Cls II)

    ORL Kids Natural Toothpaste, Bubblegum Flavor, 4 oz (120ml), ORL Labs, LLC, Scottsdale, Arizona USA — Reason: cGMP Deviations — Status: Ongoing

    full page →fda recalls ↗
    ›Jan 14, 2026recall209d agoAvKARE recall (Cls II)AvKare LLC

    Rosuvastatin Tablets, USP, 10 mg, Rx Only, 50 Tablets (5 x 10) Unit Dose per carton, Manufactured for: AvKARE, Pulaski, TN 38478. NDC: 50268-709-15 — Reason: Out of specification for dissolution. — Status: Ongoing

    full page →fda recalls ↗
    ›Jan 14, 2026recall209d agoAlembic Pharmaceuticals Limited recall (Cls III)Alembic Pharmaceuticals Inc

    Fesoterodine Fumarate, Extended-release Tablets, 8 mg, 30 Tablets, Rx only, Manufactured by: Alembic Pharmaceuticals Limited, Panelav 389350, Gujarat, India, Manufactured for: Alembic Pharmaceuticals, Inc., Bedminster, NJ 07921, USA, NDC 62332-176-30 — Reason: Failed Impurities/Degradation Specifications: Due to levels of 'Diester Impurity' exceeding the specification limit. — Status: Ongoing

    full page →fda recalls ↗
    ›Jan 14, 2026recall209d agoImprimis NJOF, LLC recall (Cls II)OCULAR THERAPEUTIX, INC

    Dexamethasone Moxifloxacin Ketorolac, 1 mg/mL, 0.5 mg/mL, 0.4 mg/mL) Single-Use Intraocular Injection, Imprimis NJOF, LLC., 1705 Route 46 West, Unit 6B, Ledgewood, NJ 07852, NDC 71384-513-01. — Reason: Presence of particulate matter - Glass like particles. — Status: Ongoing

    full page →fda recalls ↗
    ›Jan 14, 2026recall209d agoImprimis NJOF, LLC recall (Cls II)OCULAR THERAPEUTIX, INC

    Dexamethasone Moxifloxacin, 1 mg/mL and 5 mg/mL, 1 mL Intraocular Injection, Rx only, Imprimis NJOF, LLC, Ledgewood, NJ 07852, NDC 71384-512-0.1 — Reason: Presence of particulate matter - Glass like particles. — Status: Ongoing

    full page →fda recalls ↗
    ›Jan 14, 2026grant209d agoLOUISIANA STATE UNIV A&M COL BATON ROUGE — Role of host glutaminolysis in tuberculosis pathogenesis

    GM grant. $196,875. PI: Stephania A Cormier

    full page →nih reporter ↗
    ›Jan 15, 2026grant208d agoUNIVERSITY OF WISCONSIN MILWAUKEE — Effects of older age on the neural basis of memory generalization

    AG grant. $293,454. PI: Caitlin R. Bowman

    full page →nih reporter ↗
    ›Jan 15, 2026grant208d agoMIRIAM HOSPITAL — Applying a just-in-time adaptive intervention framework to understand and tre...

    GM grant. $223,500. PI: KayLoni L. Olson

    full page →nih reporter ↗
    ›Jan 15, 2026grant208d agoUNIVERSITY OF CALIFORNIA, SAN FRANCISCO — Preclinical development of breakthrough immunotherapy for brain tumorsUniversity of California San Francisco

    NS grant. $943,253. PI: Hideho Okada

    full page →nih reporter ↗
    ›Jan 15, 2026grant208d agoUNIVERSITY OF IOWA — Determining the Impact of Metabolic Syndrome on the Oral Microbiome and Perio...University of Iowa

    DE grant. $699,184. PI: Sukirth Murthy Ganesan

    full page →nih reporter ↗
    ›Jan 15, 2026grant208d agoNEW YORK UNIVERSITY SCHOOL OF MEDICINE — (Micro)structural Biomarkers of Skeletal Muscle Health Across the LifespanNew York University

    AG grant. $466,125. PI: Valentina Mazzoli

    full page →nih reporter ↗
    ›Jan 15, 2026grant208d agoWEST VIRGINIA UNIVERSITY — Nanoscale synaptic heterogeneity, loss, and plasticity in Alzheimer's diseaseMetallomix Inc

    AG grant. $476,159. PI: Martin Hruska

    full page →nih reporter ↗
    ›Jan 15, 2026grant208d agoUNIVERSITY OF CALIFORNIA BERKELEY — Photoactivation of Supramolecular Hosts: Novel Chemical Reactivity Through Ph...

    GM grant. $1. PI: Katherine Carmen Forbes

    full page →nih reporter ↗
    ›Jan 15, 2026grant208d agoUNIVERSITY OF DELAWARE — Novel in situ analysis of the functional impacts of osteoarthritis in the mou...

    AG grant. $560,380. PI: Stephanie Grace Cone

    full page →nih reporter ↗
    ›Jan 15, 2026grant208d agoCOLUMBIA UNIVERSITY HEALTH SCIENCES — Mitochondrial and energetic underpinnings of resilience in human aging: integ...

    AG grant. $690,865. PI: Alan A. Cohen

    full page →nih reporter ↗
    ›Jan 15, 2026grant208d agoNORTH CAROLINA STATE UNIVERSITY RALEIGH — BOWiD: a tool for lifelong tracking C. elegans individuals using stochastical...

    AG grant. $580,636. PI: Adriana San Miguel

    full page →nih reporter ↗
    ›Jan 15, 2026grant208d agoUNIVERSITY OF PENNSYLVANIA — Investigating the Role of Genetic Variants and Aging on Eicosanoid Metabolism...University of Pennsylvania

    AG grant. $446,875. PI: Eleonora Scorletti

    full page →nih reporter ↗
    ›Jan 15, 2026grant208d agoUT SOUTHWESTERN MEDICAL CENTER — Identification of metabolic regulators of hepatic phosphatidylcholine synthesis

    DK grant. $676,279. PI: Javier Garcia Bermudez

    full page →nih reporter ↗
    ›Jan 15, 2026grant208d agoNEW YORK UNIVERSITY SCHOOL OF MEDICINE — GABAergic Circuit Targets for Modulating Entorhinal Cortex and Hippocampal Dy...New York University

    AG grant. $642,063. PI: Jayeeta Basu

    full page →nih reporter ↗
    ›Jan 15, 2026grant208d agoWASHINGTON UNIVERSITY — Transgenerational Adaptation of Longevity Changes in Response to Repeated Env...

    AG grant. $556,121. PI: Eric Lieberman Greer

    full page →nih reporter ↗
    ›Jan 15, 2026grant208d agoUNIVERSITY OF ALABAMA AT BIRMINGHAM — AMPA Receptor Function at Interneuron Synapses

    NS grant. $186,250. PI: Jacques Wadiche

    full page →nih reporter ↗
    ›Jan 15, 2026grant208d agoSTANFORD UNIVERSITY — The brain as a control center for other organs during agingStanford University

    AG grant. $1,468,868. PI: ANNE BRUNET

    full page →nih reporter ↗
    $NVO47.73+0.99%
    $NVO47.73+0.99%
    $LBRX45.85-4.48%
    $LBRX45.85-4.48%
    $OCUL9.2400+0.54%
    $OCUL9.2400+0.54%